About
Lev-El Diagnostics is a medical technology company specializing in the noninvasive detection of cardiovascular diseases. The companys initial product, HeartTrends, is a cardiac stress test alternative. HeartTrends is designed to assist in the detection of myocardial ischemia related to coronary artery disease (CAD) at an early stage. HeartTrends can be used as a general tool for screening both sick and healthy individuals. The HeartTrends software analyzes R-R interval measurements captured from a certified, off-the-shelf Holter monitor during a short at-rest heart test. Immediately following the procedure, HeartTrends can generate a Dy/Dx indicator value to assist qualified personnel in detecting myocardial ischemia related to CAD.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Lev El Diagnostic's primary product?
- Lev El Diagnostic's primary product is HeartTrends, a software solution designed for the noninvasive detection of cardiovascular diseases, serving as an alternative to the cardiac stress test.
- What is the purpose of the HeartTrends software?
- The HeartTrends software assists in the early detection of myocardial ischemia related to coronary artery disease (CAD) by analyzing R-R interval measurements from a Holter monitor during an at-rest heart test.
- When was Lev El Diagnostic founded?
- Lev El Diagnostic was founded in January 2013.
- Where is Lev El Diagnostic headquartered?
- Lev El Diagnostic is headquartered in Ra'anana, Israel.
- How many employees does Lev El Diagnostic currently have?
- Lev El Diagnostic currently has 1-10 employees.
- What was the outcome of the multi-center clinical study for HeartTrends in November 2019?
- In November 2019, a multi-center clinical study demonstrated that HeartTrends improved early detection for heart disease in healthy individuals.
- What was reported about Lev El Diagnostic's algorithm in December 2019?
- In December 2019, it was reported that Lev El Diagnostic's algorithm identifies a new risk factor for heart disease, though a doctor expressed skepticism.
- What claim did Lev El Diagnostic make about its test for coronary artery disease in April 2015?
- In April 2015, Lev El Diagnostic announced a breakthrough test for early detection of coronary artery disease, claiming it was superior to exercise stress testing.
- Who is a founder of Lev El Diagnostic?
- Jacob Levitan is a founder of Lev El Diagnostic.